----

| Nevada                                                         | 20-5046886                           |   |
|----------------------------------------------------------------|--------------------------------------|--------|
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |   |

----

----

----

Table

|                                 |                                                                                        |   | Page   |     |
|--------------------------------------|---------------------------------------------------------------------------------------------|--------|--------|----------|
| PART I – FINANCIAL INFORMATION |                                                                                        |   |   |
| Item 1.                              | Financial Statements                                                                        |   |   | 1        |   |
| Item 2.                              | Management’s Discussion and Analysis of Financial Condition and Results of Operations |   |   | 12       |   |
| Item 3.                              | Quantitative and Qualitative Disclosures About Market Risk                                  |   |   | 18       |   |
| Item 4T.                             | Controls and Procedures                                                                     |   |   | 18       |   |
|                                 |                                                                                        |   |   |     |   |
| PART II – OTHER INFORMATION    |                                                                                        |   |   |     |
| Item 1.                              | Legal Proceedings                                                                           |   |   | 19       |   |
| Item 1A.                             | Risk Factors                                                                                |   |   | 19       |   |
| Item 2.                              | Unregistered Sales of Equity Securities and Use of Proceeds                                 |   |   | 19       |   |
| Item 3.                              | Defaults Upon Senior Securities                                                             |   |   | 19       |   |
| Item 4.                              | Submission of Matters to a Vote of Security Holders                                         |   |   | 19       |   |
| Item 5.                              | Other Information                                                                           |   |   | 19       |   |
| Item 6.                              | Exhibits                                                                                    |   |   | 19       |   |
|                                 |                                                                                        |   |   |  19 |   |
| SIGNATURES                           |                                                                                        |   | 19     |     |
|                                 |                                                                                        |   |   |     |   |
| EXHIBIT INDEX                        |                                                                                        |   | 20     |     |

----

----

----

Item 1

| ASSETS                      |   | June 30, 2009(Unaudited) |   |   | December 31, 2008(Audited) |   |
|-----------------------------|--------|--------------------------|--------|--------|----------------------------|--------|
|                        |   |                     |   |   |                       |   |
| Current assets:             |   |                     |   |   |                       |   |
| Cash and cash equivalents   |   | $                        | 4,696  |   |                       | $      | 32,891 |   |
| Trade accounts receivable   |   |                     | 1,500  |   |                       |   | - |   |
| Inventory                   |   |                     | 1,225  |   |                       |   | 2,047 |   |
| Prepaid expenses            |   |                     | 4,666  |   |                       |   | - |   |
|                        |   |                     |   |   |                       |   |   |   |
| Total current assets        |   |                     | 12,087 |   |                       |   | 34,938 |   |
|                        |   |                     |   |   |                       |   |   |   |
| Property and equipment, net |   |                     | 6,693  |   |                       |   | 7,228 |   |
|                        |   |                     |   |   |                       |   |   |   |
| Total assets                |   | $                        | 18,780 |   |                       | $      | 42,166 |   |

Table of Contents

----

----

----

| LIABILITIES AND SHAREHOLDERS’ DEFICIT                                                                                                                |   |    June 30, 2009(Unaudited) |    | December 31, 2008(Audited)    |    |
|------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------------|---------|-------------------------------|---------|
|                                                                                                                                                       |   |                                  |    |                          |    |
| Current liabilities:                                                                                                                                       |   |                                  |    |                          |    |
| Current portion of note payable - shareholder, net                                                                                                         | $      | 338,047                               | $       |  -                       |    |
| Trade accounts payable                                                                                                                                     |   | 59,070                                |    | 30,172                        |    |
| Accrued expenses                                                                                                                                           |   | 25,270                                |    | 12,101                        |    |
| Loan payable to shareholder/officer                                                                                                                        |   | 10,000                                |    | -                             |    |
| Accrued directors’ fees                                                                                                                              |   | 14,000                                |    | 7,000                         |    |
| Accrued officer’s compensation                                                                                                                       |   | 330,306                               |    | 218,806                       |    |
|                                                                                                                                                       |   |                                  |    |                          |    |
| Total current liabilities                                                                                                                                  |   | 776,693                               |    | 268,079                       |    |
|                                                                                                                                                       |   |                                  |    |                          |    |
| Note payable - shareholder, net                                                                                                                            |   | -                                     |    | 296,745                       |    |
|                                                                                                                                                       |   |                                  |    |                          |    |
| Total liabilities                                                                                                                                          |   | 776,693                               |    | 564,824                       |    |
|                                                                                                                                                       |   |                                  |    |                          |    |
| Shareholders’ deficit:                                                                                                                               |   |                                  |    |                          |    |
| Common stock, $.001 par value; 50,000,000 shares authorized; 13,480,938 and 13,380,938 shares issued and outstanding at 6/30/09 and 12/31/08, respectively |   | 13,480                                |    | 13,380                        |    |
| Additional paid-in-capital                                                                                                                                 |   | 745,566                               |    | 726,666                       |    |
| Accumulated deficit                                                                                                                                        |   |   (1,516,959                     | )  |     (1,262,704 | )  |
|                                                                                                                                                       |   |                                  |    |                          |    |
| Total shareholders’ deficit                                                                                                                          |   |  (757,913                        | )  |  (522,658                | )  |
|                                                                                                                                                       |   |                                  |    |                          |    |
| Total liabilities and shareholders’ deficit                                                                                                          | $      | 18,780                                | $       | 42,166                        |    |
|                                                                                                                                                       |   |                                  |    |                          |    |

Table of Contents

----

----

----

|                                                         |   | Three Months Ended |       |   | Six Months Ended |   |
|--------------------------------------------------------------|--------|--------------------|------------|--------|------------------|--------|
|                                                         |   | June 30,           |       |   | June 30,         |   |
|                                                         |   |               |       |   |             |   |   |
|                                                         |   | 2009               |       |   | 2008             |   |   | 2009 |   |   | 2008 |   |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |
| Net sales                                                    |   | $                  | 2,367      |   |             | $      | 1,526 |   |   | $ | 7,178 |   |   | $ | 117,795 |   |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Cost of goods sold                                           |   |               | 524        |   |             |   | 850 |   |   |   | 2,974 |   |   |   | 101,472 |   |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Gross profit                                                 |   |               | 1,843      |   |             |   | 676 |   |   |   | 4,204 |   |   |   | 16,323 |   |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Operating expenses                                           |   |               | 90,555     |   |             |   | 116,938 |   |   |   | 195,209 |   |   |   | 236,103 |   |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Operating loss                                               |   |               | (88,712    | )      |             |   | (116,262 | ) |   |   | (191,005 | ) |   |   | (219,780 | ) |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Other income (expense):                                      |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Interest income                                              |   |               | -          |   |             |   | 764 |   |   |   | 52 |   |   |   | 2,746 |   |
| Interest expense                                             |   |               | (30,651    | )      |             |   | (31,875 | ) |   |   | (63,302 | ) |   |   | (63,750 | ) |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Total other income (expense)                                 |   |               | (30,651    | )      |             |   | (31,111 | ) |   |   | (63,250 | ) |   |   | (61,004 | ) |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net loss before income taxes                                 |   |               | (119,363   | )      |             |   | (147,373 | ) |   |   | (254,255 | ) |   |   | (280,784 | ) |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Income tax provision                                         |   |               | -          |   |             |   | - |   |   |   | - |   |   |   | - |   |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                                     |   | $                  | (119,363   | )      |             | $      | (147,373 | ) |   | $ | (254,255 | ) |   | $ | (280,784 | ) |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted loss per common share                      |   | $                  | (0.01      | )      |             | $      | (0.01 | ) |   | $ | (0.02 | ) |   | $ | (0.02 | ) |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted weighted average common shares outstanding |   |               | 13,425,993 |   |             |   | 13,069,909 |   |   |   | 13,403,590 |   |   |   | 11,979,173 |   |
|                                                         |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |

Table of Contents

----

----

----

|                                                                              |   | Six Months Ended |     |
|-----------------------------------------------------------------------------------|--------|------------------|----------|
|                                                                              |   | June 30,         |     |
|                                                                              |   | 2009             |     |   | 2008 |   |
|                                                                              |   |             |     |   |   |   |
| Cash flows from operating activities:                                             |   |             |     |   |   |   |
| Net loss                                                                          |   | $                | (254,255 | ) |   | $ | (280,784 | ) |
| Adjustments to reconcile net loss to net cash flows used in operating activities: |   |             |     |   |   |   |   |   |
| Depreciation and amortization                                                     |   |             | 1,583    |   |   |   | 2,452 |   |
| Amortization of debt discount                                                     |   |             | 41,302   |   |   |   | 43,750 |   |
| Related party exchange of stock for interest                                      |   |             | 12,000   |   |   |   | - |   |
| Common stock issued for services                                                  |   |             | 7,000    |   |   |   | - |   |
| Changes in operating assets and liabilities:                                      |   |             |     |   |   |   |   |   |
| Accounts receivable                                                               |   |             | (1,500   | ) |   |   | 6,901 |   |
| Prepaids                                                                          |   |             | (4,666   | ) |   |   | - |   |
| Inventory                                                                         |   |             | 822      |   |   |   | (605 | ) |
| Accounts payable                                                                  |   |             | 28,898   |   |   |   | 13,521 |   |
| Accrued expenses                                                                  |   |             | 13,169   |   |   |   | (17,397 | ) |
| Accrued directors’ fees                                                     |   |             | 7,000    |   |   |   | 7,500 |   |
| Accrued officer’s compensation                                              |   |             | 111,500  |   |   |   | 98,052 |   |
| Deferred revenue                                                                  |   |             | -        |   |   |   | (4,200 | ) |
|                                                                              |   |             |     |   |   |   |   |   |
| Net cash flows used in operating activities                                       |   |             | (37,147  | ) |   |   | (130,810 | ) |
|                                                                              |   |             |     |   |   |   |   |   |
| Cash flows from investing activities:                                             |   |             |     |   |   |   |   |   |
| Purchases of property and equipment                                               |   |             | (1,048   | ) |   |   | (1,075 | ) |
|                                                                              |   |             |     |   |   |   |   |   |
| Net cash flows used in investing activities                                       |   |             | (1,048   | ) |   |   | (1,075 | ) |
|                                                                              |   |             |     |   |   |   |   |   |
| Cash flows from financing activities:                                             |   |             |     |   |   |   |   |   |
|       Loan from shareholder/officer                 |   |             | 10,000   |   |   |   | - |   |
|                                                                              |   |             |     |   |   |   |   |   |
| Net cash flows provided by financing activities                                   |   |             | 10,000   |   |   |   | - |   |
|                                                                              |   |             |     |   |   |   |   |   |
| Net change in cash                                                                |   |             | (28,195  | ) |   |   | (131,885 | ) |
|                                                                              |   |             |     |   |   |   |   |   |
| Cash and cash equivalents, beginning of year                                      |   |             | 32,891   |   |   |   | 271,082 |   |
|                                                                              |   |             |     |   |   |   |   |   |
| Cash and cash equivalents, end of year                                            |   | $                | 4,696    |   |   | $ | 139,197 |   |
|                                                                              |   |             |     |   |   |   |   |   |
| Supplemental disclosure of cash flow information:                                 |   |             |     |   |   |   |   |   |
| Cash paid during the year for interest                                            |   | $                | -        |   |   | $ | 30,000 |   |
|                                                                              |   |             |     |   |   |   |   |   |
| Non-cash financing activities:                                                    |   |             |     |   |   |   |   |   |
|                                                                              |   |             |     |   |   |   |   |   |
| Issuance of common stock for services previously accrued                          |   | $                | -        |   |   | $ | 329,488 |   |
|                                                                              |   |             |     |   |   |   |   |   |
|                                                                              |   |             |     |   |   |   |   |   |
|                                                                              |   |             |     |   |   |   |   |   |

Table of Contents

----

----

----

Table of Contents

----

----

----

|     |   |   | 2009            |   |   | 2008          |   |
|----------|--------|--------|-----------------|--------|--------|---------------|--------|
| Customer |   |   | Percentof Sales |   |   | Percentof A/R |   |   | Percentof Sales |   |   | Percentof A/R |   |
|     |   |   |            |   |   |          |   |   |   |   |   |   |   |
|     | A      |   |            |   | 56     | %             |   |   | 100 | % |   |   | - |   |   |   | - |   |
|     | B      |   |            |   | 11     | %             |   |   | - |   |   |   | - |   |   |   | - |   |
|     | C      |   |            |   | -      |          |   |   | - |   |   |   | 90 | % |   |   | - |   |

|          |   | 2009   |   |   | 2008   |   |
|---------------|--------|--------|--------|--------|--------|--------|
|          |   |   |   |   |   |   |
| United States |   | $      | 2,008  |   |   | $      | 4,533 |   |
| Mexico        |   |   | 371    |   |   |   | - |   |
| Japan         |   |   | 4,040  |   |   |   | 765 |   |
| Pakistan      |   |   | -      |   |   |   | 7,178 |   |
| Australia     |   |   | 759    |   |   |   | - |   |
| Nigeria       |   |   | -      |   |   |   | 105,000 |   |
| Other         |   |   | -      |   |   |   | 319 |   |
|          |   | $      | 7,178  |   |   | $      | 117,795 |   |
|          |   |   |   |   |   |   |   |   |

| Balance December 31, 2006                             |   | $      | -        |   |
|-------------------------------------------------------|--------|--------|----------|--------|
| Gross Proceeds                                        |   |   | 400,000  |   |
| Less: Discount allocated to the warrants              |   |   | (175,000 | )      |
| Add:  Amortization of debt discount         |   |   | 58,333   |   |
|                                                  |   |   |     |   |
| Balance December 31, 2007                             |   |   | 283,333  |   |
| Add:  Amortization of debt discount         |   |   | 54,298   |   |
| Less:  Extinguishment of debt               |   |   | (337,631 | )      |
| Add:  Fair value of amended Note            |   |   | 265,201  |   |
| Add:  Amortization of amended Note discount |   |   | 31,544   |   |
|                                                  |   |   |     |   |
| Balance December 31, 2008                             |   |   | 296,745  |   |
| Add:  Amortization of amended Note discount |   |   | 41,302   |   |
|                                                  |   |   |     |   |
| Balance June 30, 2009 (face value of $400,000)        |   | $      | 338,047  |   |
|                                                  |   |   |     |   |

| 2009   |   | $      | -       |   |
|--------|--------|--------|---------|--------|
| 2010   |   |   | 400,000 |   |
|   |   | $      | 400,000 |   |

Table of Contents

----

----

Table of Contents

----

----

----

|                                    |   | Three Months EndedJune 30, |       |   | Six Months EndedJune 30, |   |
|-----------------------------------------|--------|----------------------------|------------|--------|--------------------------|--------|
|                                    |   |                       |       |   |                     |   |   |   |   |   |   |   |
|                                    |   | 2009                       |       |   | 2008                     |   |   | 2009 |   |   | 2008 |   |
| Basic earnings per share calculation:   |   |                       |       |   |                     |   |   |   |   |   |   |   |
| Net loss to common shareholders         |   | $                          | (119,363   | )      |                     | $      | (147,373 | ) |   | $ | (254,255 | ) |   | $ | (280,784 | ) |
|                                    |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average of common shares       |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
|     outstanding     |   |                       | 13,425,993 |   |                     |   | 13,069,909 |   |   |   | 13,403,590 |   |   |   | 11,979,173 |   |
|                                    |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Basic net loss per share                |   | $                          | (0.01      | )      |                     | $      | (0.01 | ) |   | $ | (0.02 | ) |   | $ | (0.02 | ) |
|                                    |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Diluted earnings per share calculation: |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Net loss to common shareholders         |   | $                          | (119,363   | )      |                     | $      | (147,373 | ) |   | $ | (254,255 | ) |   | $ | (280,784 | ) |
|                                    |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average of common shares       |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
|     outstanding     |   |                       | 13,425,993 |   |                     |   | 13,069,909 |   |   |   | 13,403,590 |   |   |   | 11,979,173 |   |
| Warrants (1)                            |   |                       | -          |   |                     |   | - |   |   |   | - |   |   |   | - |   |
| Diluted weighted average common shares  |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
|     outstanding     |   |                       | 13,425,993 |   |                     |   | 13,069,909 |   |   |   | 13,403,590 |   |   |   | 11,979,173 |   |
|                                    |   |                       |       |   |                     |   |   |   |   |   |   |   |   |   |   |   |
| Diluted net loss per share              |   | $                          | (0.01      | )      |                     | $      | (0.01 | ) |   | $ | (0.02 | ) |   | $ | (0.02 | ) |

| (1)   | The 200,000 shares of warrants outstanding were anti-dilutive due to the Company’s net loss for the three and six months ended June 30, 2009 and 2008, therefore they have been excluded from the calculation. |
|-----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

Table of Contents

----

----

----

Table of Contents

----

----

----

| Six Months Ended June 30, 2009  |   | Fishmeal |   |   | Health Supplements |   |   | Corporate & Other |   |   | Total    |   |
|---------------------------------|--------|----------|--------|--------|--------------------|--------|--------|-----------------------|--------|--------|----------|--------|
| Net Sales                       |   | $        | -      |   |               | $      | 5,678  |                  |   | $      | 1,500    |   |   | $ | 7,178 |   |
| Gross Profit                    |   | $        | -      |   |               | $      | 3,704  |                  |   | $      | 500      |   |   | $ | 4,204 |   |
| Operating Income (Loss)         |   | $        | -      |   |               | $      | 3,503  |                  |   | $      | (194,508 | )      |   | $ | (191,005 | ) |
| Interest Income                 |   | $        | -      |   |               | $      | -      |                  |   | $      | 52       |   |   | $ | 52 |   |
| Interest Expense                |   | $        | -      |   |               | $      | -      |                  |   | $      | 63,302   |   |   | $ | 63,302 |   |
| Depreciation & Amortization |   | $        | -      |   |               | $      | 201    |                  |   | $      | 1,382    |   |   | $ | 1,583 |   |
| Identifiable Net Assets         |   | $        | -      |   |               | $      | 3,536  |                  |   | $      | 15,244   |   |   | $ | 18,780 |   |

| Six Months Ended June 30, 2008  |   | Fishmeal |    |   | Health Supplements |   |   | Corporate & Other |   |   | Total    |   |
|---------------------------------|--------|----------|---------|--------|--------------------|--------|--------|-----------------------|--------|--------|----------|--------|
| Net Sales                       |   | $        | 105,765 |   |               | $      | 12,030 |                  |   | $      | -        |   |   | $ | 117,795 |   |
| Gross Profit                    |   | $        | 8,356   |   |               | $      | 7,967  |                  |   | $      | -        |   |   | $ | 16,323 |   |
| Operating Income (Loss)         |   | $        | 8,356   |   |               | $      | 5,861  |                  |   | $      | (233,997 | )      |   | $ | (219,780 | ) |
| Interest Income                 |   | $        | -       |   |               | $      | -      |                  |   | $      | 2,746    |   |   | $ | 2,746 |   |
| Interest Expense                |   | $        | -       |   |               | $      | -      |                  |   | $      | 63,750   |   |   | $ | 63,750 |   |
| Depreciation & Amortization |   | $        | -       |   |               | $      | 625    |                  |   | $      | 1,827    |   |   | $ | 2,452 |   |
| Identifiable Net Assets         |   | $        | -       |   |               | $      | 4,387  |                  |   | $      | 148,224  |   |   | $ | 152,611 |   |

| Three Months Ended June 30, 2009 |   | Fishmeal |   |   | Health Supplements |   |   | Corporate & Other |   |   | Total   |   |
|----------------------------------|--------|----------|--------|--------|--------------------|--------|--------|-----------------------|--------|--------|---------|--------|
| Net Sales                        |   | $        | -      |   |               | $      | 2,367  |                  |   | $      | -       |   |   | $ | 2,367 |   |
| Gross Profit                     |   | $        | -      |   |               | $      | 1,843  |                  |   | $      | -       |   |   | $ | 1,843 |   |
| Operating Income (Loss)          |   | $        | -      |   |               | $      | 1,278  |                  |   | $      | (89,990 | )      |   | $ | (88,712 | ) |
| Interest Income                  |   | $        | -      |   |               | $      | -      |                  |   | $      | -       |   |   | $ | - |   |
| Interest Expense                 |   | $        | -      |   |               | $      | -      |                  |   | $      | 30,651  |   |   | $ | 30,651 |   |
| Depreciation & Amortization  |   | $        | -      |   |               | $      | 100    |                  |   | $      | 706     |   |   | $ | 806 |   |
| Identifiable Net Assets          |   | $        | -      |   |               | $      | 3,536  |                  |   | $      | 15,244  |   |   | $ | 18,780 |   |

| Three Months Ended June 30, 2008 |   | Fishmeal |   |   | Health Supplements |   |   | Corporate & Other |   |   | Total    |   |
|----------------------------------|--------|----------|--------|--------|--------------------|--------|--------|-----------------------|--------|--------|----------|--------|
| Net Sales                        |   | $        | -      |   |               | $      | 1,526  |                  |   | $      | -        |   |   | $ | 1,526 |   |
| Gross Profit                     |   | $        | -      |   |               | $      | 676    |                  |   | $      | -        |   |   | $ | 676 |   |
| Operating Income (Loss)          |   | $        | -      |   |               | $      | 181    |                  |   | $      | (116,443 | )      |   | $ | (116,262 | ) |
| Interest Income                  |   | $        | -      |   |               | $      | -      |                  |   | $      | 764      |   |   | $ | 764 |   |
| Interest Expense                 |   | $        | -      |   |               | $      | -      |                  |   | $      | 31,875   |   |   | $ | 31,875 |   |
| Depreciation & Amortization  |   | $        | -      |   |               | $      | 312    |                  |   | $      | 922      |   |   | $ | 1,234 |   |
| Identifiable Net Assets          |   | $        | -      |   |               | $      | 4,387  |                  |   | $      | 148,224  |   |   | $ | 152,611 |   |

Table of Contents

----

----

----

Table of Contents

----

|   | Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
|--------|-----------------------------------------------------------------------------------------------------------------|

| ·   | Our need for additional financing to fund operations and capital expansion of our fishmeal business |
|--------------------|-----------------------------------------------------------------------------------------------------|

| ·   | Our inability to successfully market and develop our heating technologies and fertilizing products |
|--------------------|----------------------------------------------------------------------------------------------------|

| ·   | Our inability to protect our intellectual property and developing technologies, or |
|--------------------|------------------------------------------------------------------------------------|

| ·   | Our inability, for any reason, to retain our executive management personnel. |
|--------------------|------------------------------------------------------------------------------|

Table of Contents

----

----

----

| ·   | Fishmeal – we buy and resell fishmeal for use as a high-protein ingredient in animal feed and organic fertilizers. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------|

| ·   | Health Supplements – we manufacture and sell health supplements that incorporate fish oil and multiple herbs (primarily from South America) as ingredients. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Heating Technology – we are developing energy-efficient products based on a novel patent-pending heating technology. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------|

| ·   | Fertilizing – we have completed the development of organic fish-based plant fertilizers for commercial sale, and are presently involved in marketing our fertilizing products. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

Table of Contents

----

----

----

|                            |   | Fishmeal |    |   | Health Supplements |   |   | Corporate & Other |   |   | Total    |   |
|---------------------------------|--------|----------|---------|--------|--------------------|--------|--------|-----------------------|--------|--------|----------|--------|
| Six Months EndedJune 30, 2009   |   |     |    |   |               |   |   |                  |   |   |     |   |
| Revenues                        |   | $        | -       |   |               | $      | 5,678  |                  |   | $      | 1,500    |   |   | $ | 7,178 |   |
| Gross Profit                    |   | $        | -       |   |               | $      | 3,704  |                  |   | $      | 500      |   |   | $ | 4,204 |   |
| Operating income (loss)         |   | $        | -       |   |               | $      | 3,503  |                  |   | $      | (194,508 | )      |   | $ | (191,005 | ) |
| Interest income                 |   | $        | -       |   |               | $      | -      |                  |   | $      | 52       |   |   | $ | 52 |   |
| Interest expense                |   | $        | -       |   |               | $      | -      |                  |   | $      | 63,302   |   |   | $ | 63,302 |   |
| Depreciation & amortization |   | $        | -       |   |               | $      | 201    |                  |   | $      | 1,382    |   |   | $ | 1,583 |   |
| Identifiable net assets         |   | $        | -       |   |               | $      | 3,536  |                  |   | $      | 15,244   |   |   | $ | 18,780 |   |
|                            |   |     |    |   |               |   |   |                  |   |   |     |   |   |   |   |   |
| Six Months EndedJune 30, 2008   |   |     |    |   |               |   |   |                  |   |   |     |   |   |   |   |   |
| Revenues                        |   | $        | 105,765 |   |               | $      | 12,030 |                  |   | $      | -        |   |   | $ | 117,795 |   |
| Gross Profit                    |   | $        | 8,356   |   |               | $      | 7,967  |                  |   | $      | -        |   |   | $ | 16,323 |   |
| Operating income (loss)         |   | $        | 8,356   |   |               | $      | 5,861  |                  |   | $      | (233,997 | )      |   | $ | (219,780 | ) |
| Interest income                 |   | $        | -       |   |               | $      | -      |                  |   | $      | 2,746    |   |   | $ | 2,746 |   |
| Interest expense                |   | $        | -       |   |               | $      | -      |                  |   | $      | 63,750   |   |   | $ | 63,750 |   |
| Depreciation & amortization |   | $        | -       |   |               | $      | 625    |                  |   | $      | 1,827    |   |   | $ | 2,452 |   |
| Identifiable net assets         |   | $        | -       |   |               | $      | 4,387  |                  |   | $      | 148,224  |   |   | $ | 152,611 |   |
|                            |   |     |    |   |               |   |   |                  |   |   |     |   |   |   |   |   |

Table of Contents

----

----

----

|                            |   | Fishmeal |   |   | Health Supplements |   |   | Corporate & Other |   |   | Total    |   |
|---------------------------------|--------|----------|--------|--------|--------------------|--------|--------|-----------------------|--------|--------|----------|--------|
| Three Months EndedJune 30, 2009 |   |     |   |   |               |   |   |                  |   |   |     |   |
| Revenues                        |   | $        | -      |   |               | $      | 2,367  |                  |   | $      | -        |   |   | $ | 2,367 |   |
| Gross Profit                    |   | $        | -      |   |               | $      | 1,843  |                  |   | $      | -        |   |   | $ | 1,843 |   |
| Operating income (loss)         |   | $        | -      |   |               | $      | 1,278  |                  |   | $      | (89,990  | )      |   | $ | (88,712 | ) |
| Interest income                 |   | $        | -      |   |               | $      | -      |                  |   | $      | -        |   |   | $ | - |   |
| Interest expense                |   | $        | -      |   |               | $      | -      |                  |   | $      | 30,651   |   |   | $ | 30,651 |   |
| Depreciation & amortization |   | $        | -      |   |               | $      | 100    |                  |   | $      | 706      |   |   | $ | 806 |   |
| Identifiable net assets         |   | $        | -      |   |               | $      | 3,536  |                  |   | $      | 15,244   |   |   | $ | 18,780 |   |
|                            |   |     |   |   |               |   |   |                  |   |   |     |   |   |   |   |   |
| Three Months EndedJune 30, 2008 |   |     |   |   |               |   |   |                  |   |   |     |   |   |   |   |   |
| Revenues                        |   | $        | -      |   |               | $      | 1,526  |                  |   | $      | -        |   |   | $ | 1,526 |   |
| Gross Profit                    |   | $        | -      |   |               | $      | 676    |                  |   | $      | -        |   |   | $ | 676 |   |
| Operating income (loss)         |   | $        | -      |   |               | $      | 181    |                  |   | $      | (116,443 | )      |   | $ | (116,262 | ) |
| Interest income                 |   | $        | -      |   |               | $      | -      |                  |   | $      | 764      |   |   | $ | 764 |   |
| Interest expense                |   | $        | -      |   |               | $      | -      |                  |   | $      | 31,875   |   |   | $ | 31,875 |   |
| Depreciation & amortization |   | $        | -      |   |               | $      | 312    |                  |   | $      | 922      |   |   | $ | 1,234 |   |
| Identifiable net assets         |   | $        | -      |   |               | $      | 4,387  |                  |   | $      | 148,224  |   |   | $ | 152,611 |   |
|                            |   |     |   |   |               |   |   |                  |   |   |     |   |   |   |   |   |

Table of Contents

----

----

----

|                              | Six Months Ended June 30, |   |
|----------------------------------------|-------------------------------------|--------|
|                                   | 2009                                |   | 2008 |   |
|                                   |                                |   |   |   |
| Cash flows provided (used) by :        |                                |   |   |   |
|    Operating activities |                                | $      | (37,147 | ) |   | $ | (130,810 | ) |
|    Investing activities |                                |   | (1,048 | ) |   |   | (1,075 | ) |
|    Financing activities |                                |   | 10,000 |   |   |   | - |   |
| Net decrease in cash                   |                                |   | (28,195 | ) |   |   | (131,885 | ) |
| Cash, beginning of period              |                                |   | 32,891 |   |   |   | 271,082 |   |
| Cash, end of period                    |                                | $      | 4,696 |   |   |   | 139,197 |   |

Table of Contents

----

----

----

Table of Contents

----

----

----

Item 3.   Quantitative and Qualitative Disclosures About Market Risk.

Item 4T.  Controls and Procedures.

Table of Contents

----

----

----

Item 1.  Legal Proceedings

Item 1A.  Risk Factors.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

Item 3.  Defaults Upon Senior Securities.

Item 4.  Submission of Matters to a Vote of Security Holders.

Item 5.  Other Information.

Item 6.  Exhibits.

| Exhibit No. |   | Description                                                                                                                        |
|-------------|--------|------------------------------------------------------------------------------------------------------------------------------------|
| 31.1        |   | Certification of Chief Executive Officer                                                                                           |
| 31.2        |   | Certification of Principal Financial Officer                                                                                       |
| 32          |   | Certification of Chief Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |

|                   | Vida Life International, Ltd. |                                                         |
|------------------------|-------------------------------|--------------------------------------------------------------|
|                   |                          |                                                         |   |
| Dated: August 13, 2009 | By:                           | /s/ John C. Jordan                                      |   |
|                   |                          | John C. Jordan                                               |   |
|                   |                          | Chief Executive Officer and Principal Financial Officer |   |
|                   |                          |                                                         |   |

Table of Contents

----

| Exhibit No. |   | Description                                                                                                                             |
|-------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------|
| 31.1        |   | Certification of Chief Executive Officer                                                                                                |
| 31.2        |   | Certification of Principal Financial Officer                                                                                       |
| 32          |   | Certification of Chief Executive Officer and Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |

Table of Contents

----